Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: A randomised study

European Archives of Psychiatry and Clinical Neuroscience

Volumn 247, Issue 1, 1997, Pages 42-50

  Greil, W ^a   Ludwig Mayerhofer, W ^a   Erazo, N ^a   Engel, R R ^a   Czernik, A ^b   Giedke, H ^c   Muller Oerlinghausen B ^d   Osterheider, M ^e   Rudolf, G A E ^f   Sauer, H ^g   Tegeler, J ^h   Wetterling, T ⁱ  

^a UNIVERSITY OF MUNICH   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

^e UNIVERSITY OF WÜRZBURG   (Germany)

^f UNIVERSITY OF MÜNSTER   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h HEINRICH HEINE UNIVERSITY   (Germany)

ⁱ UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Carbamazepine; Lithium; Randomised controlled trial; Schizoaffective disorder; Treatment outcome

Indexed keywords

CARBAMAZEPINE; LITHIUM; PSYCHOTROPIC AGENT;

ADULT; APPETITE DISORDER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; FATIGUE; FEMALE; GERMANY; HOSPITALIZATION; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SATISFACTION; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; SCHIZOIDISM; SIDE EFFECT; SURVIVAL TIME; TREATMENT OUTCOME; TREMOR; XEROSTOMIA;

EID: 8044259610     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02916252     Document Type: Article

References (35)

1. Aitken, RCB (1969) Measurement of feelings using visual analogue scales. Proc R Soc Med 62 : 989-993
2. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders (DSM-III-R), 3-rd edn, revised. American Psychiatric Press, Washington, DC
3. Angst J, Dittrich A, Grof P (1969) The course of endogenous affective psychoses and its modification by prophylactic administration of imipramine and lithium. Int Pharmacopsychiatry 2 : 1-11
4. Angst J (1981) Ungelöste Probleme bei der Indikationsstellung zur Lithiumprophylaxe affektiver and schizoaffektiver Erkrankungen. Bibl Psychiatr 161 : 34-44
5. Bellaire W, Demisch K, Stoll KD (1990) Carbamazepine versus Lithium. Münch Med Wochenschr 132 [Suppl] : 82-86
6. Brockington IF, Leff JP (1979) Schizo-affective psychosis: definitions and incidence. Psychol Med 9 : 91-99
7. Brockington IF, Wainwright S, Kendell RE (1980a) Manic patients with schizophrenic or paranoid symptoms. Psychol Med 10 : 73-83
8. Brockington IF, Wainwright S, Kendell RE (1980b) Depressed patients with schizophrenic or paranoid symptoms. Psychol Med 10 : 665-675
9. Coppen A, Montgomery SA, Gupta RK, Bailey JE (1976) A double-blind comparison of lithium carbonate and maprotiline in the prophylaxis of the affective disorders. Br J Psychiatry 128 : 479-485
10. Endicott J, Spitzer RL, Fleiss JL, Cohen J (1976) The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33 : 766-771
11. Greil W, Haag M, Huber D, Schmidt St (1986) Maintenance treatment in affective disorders: overview and design of a collaborative study. Pharmacopsychiatry 19 : 167-169
12. Greil W, Ludwig-Mayerhofer W, Steller B, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GAE, Sauer H, Tegeler J, Wetterling T (1993) The recruitment process for a multicenter study on the long-term prophylactic treatment of affective disorders. J Affect Disord 28 : 257-265
13. Greil W, Ludwig-Mayerhofer W, Erazo N, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GAE, Sauer H, Tegeler J, Wetterling T (1996) Comparative efficacy of lithium and amitriptyline in the maintenance treatment of recurrent unipolar depression: a randomised study. J Affect Disord 40 : 179-190
14. Greil W, Ludwig-Mayerhofer W, Erazo N. Schmidt S, Engel RR, Czernik A, Giedke H, Müller-Oerlinghausen B, Osterheider M, Rudolf GAE, Sauer H, Tegeler J, Wetterling T (1997) Lithium versus carbamazepine in maintenance treatment of bipolar disorders: a randomised study. J Affect Disord (in press)
15. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Statistical Assoc 53 : 457-481
16. Keck PEJ, McElroy SL, Strakowski SM, West SA (1994) Pharmacologic treatment of schizoaffective disorder. Psychopharmacology 114 : 529-538
17. Kupfer DJ (1991) Long-term treatment of depression. J Clin Psychiatry 52 (Suppl 5) : 28-34
18. Lenz G, Wolf R (1986) Prophylaxe der schizoaffektiven Psychosen. In: Müller-Oerlinghausen B, Greil W (eds) Die Lithiumprophylaxe; Nutzen. Risiken, Alternativen. Springer, Berlin Heidelberg New York, pp 164-172
19. Maj M (1984a) Effectiveness of lithium prophylaxis in schizoaffective psychoses: application of a polydiagnostic approach. Acta Psychiatr Scand 70 : 228-234
20. Maj M (1984b) Evolution of the American concept of schizoaffective psychosis. Neuropsychobiology 11 : 7-13
21. Maj M (1988) Lithium prophylaxis of schizoaffective disorders: a prospective study. J Affect Disord 14 : 129-135
22. Mattes JA, Nayak D (1984) Lithium versus fluphenazine for prophylaxis in mainly schizophrenic schizo-affectives. Biol Psychiatry 19 : 445-449
23. Müller-Oeriinghausen B, Thies K, Volk J (1990) Lithium in treatment and prophylaxis of affective and schizoaffective disorders. In: Marneros A, Tsuang MT (eds) Affective and schizoaffective disorders. Springer, Berlin Heidelberg New York, pp 221-261
24. Nordic Council on Medicines (1985) Nordic drug index with classification and defined daily doses. Nordic Statistics on Medicines 1981-1983. NLN Publication no. 15, Uppsala, Sweden
25. Placidi GF, Lenzi A, Lazzerini F, Cassano GB, Akiskal HS (1986) The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients. J Clin Pschiatry 47 : 490-494
26. Prien RF (1980) Predicting lithium responders and non-responders: psychological indicators. In: Johnson FN (ed) Handbook of lithium therapy. MTP Press, Lancaster, pp 133-136
27. Prien RF (1989) Lithium in the treatment of schizophrenia and schizoaffective disorders. Arch Gen Psychiatry 36 : 852-853
28. Prien RF, Caffey EM Jr, Klett CJ (1974) Factors associated with treatment success in lithium carbonate prophylaxis. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiatry 31 : 189-192
29. Spitzer RL, Endicott J, Robins E (1982) Forschungsdiagnosekriterien (RDC) Beiz, Weinheim. [Originally Spitzer RL, Endicott J, Robins E (1978) Research Diagnostic Criteria (RDC). Biometrics Research Department, New York State Psychiatric Institute, New York]
30. Spitzer RL, Endicott J, Robins E (1982) Forschungsdiagnosekriterien (RDC) Beiz, Weinheim. [Originally Spitzer RL, Endicott J, Robins E (1978) Research Diagnostic Criteria (RDC). Biometrics Research Department, New York State Psychiatric Institute, New York]
31. Tarone RE, Ware J (1977) On distribution-free tests for equality of survival distributions. Biometrica 64 : 156-160
32. Thies-Flechtner K, Müller-Oerlinghausen B, Seibert W, Walther A, Greil W (1996) Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Pharmacopsychiatry 29 : 103-107
33. Wittchen HU, Zaudig M, Klug J, Horn R (1987) Strukturiertes Klinisches Interview für DSM-III-R (SKID) Beltz, Weinheim.
34. [Originally Spitzer RL, Williams JBW, Gibbon M (1984) Structured Clinical Interview for DSM-III-R (SCID). Biometrics Research Department, New York State Psychiatric Institute, New York
35. World Health Organisation (1978) Glossary and Guide to the Classification of Mental Disorders in Accordance with the Ninth Revision of the International Classification of Diseases. WHO, Geneva